Clinical, Conventional CT and Radiomic Feature-Based Machine Learning Models for Predicting ALK Rearrangement Status in Lung Adenocarcinoma Patients
出版年份 2020 全文链接
标题
Clinical, Conventional CT and Radiomic Feature-Based Machine Learning Models for Predicting ALK Rearrangement Status in Lung Adenocarcinoma Patients
作者
关键词
-
出版物
Frontiers in Oncology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-03-20
DOI
10.3389/fonc.2020.00369
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Predicting EGFR Mutation Status in Lung Adenocarcinoma on CT Image Using Deep Learning
- (2019) Shuo Wang et al. EUROPEAN RESPIRATORY JOURNAL
- Clinicopathological Features of ALK Expression in 9889 Cases of Non-small-Cell Lung Cancer and Genomic Rearrangements Identified by Capture-Based Next-Generation Sequencing: A Chinese Retrospective Analysis
- (2019) Ruiying Zhao et al. Molecular Diagnosis & Therapy
- Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology
- (2019) Wenting Tu et al. LUNG CANCER
- ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer
- (2019) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- CT Imaging Characteristics of Non-Small Cell Lung Cancer with Anaplastic Lymphoma Kinase (ALK) Rearrangements: A Systematic Review and Meta-analysis
- (2019) Dexter P. Mendoza et al. Clinical Lung Cancer
- Long-term follow-up of persistent pulmonary pure ground-glass nodules with deep learning–assisted nodule segmentation
- (2019) Lin-Lin Qi et al. EUROPEAN RADIOLOGY
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
- (2018) Neal I. Lindeman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer
- (2018) Evelyn E.C. de Jong et al. LUNG CANCER
- Heterogeneity in Lung Cancer
- (2018) Vitor Manuel Leitão de Sousa et al. PATHOBIOLOGY
- Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer
- (2018) Makoto Nishio et al. Cancer Research and Treatment
- Targeted Therapy With Anaplastic Lymphoma Kinase Inhibitor (Alectinib) in Adolescent Metastatic Non–Small Cell Lung Carcinoma
- (2018) Sharjeel Usmani et al. CLINICAL NUCLEAR MEDICINE
- CT-based radiomics signature for differentiating solitary granulomatous nodules from solid lung adenocarcinoma
- (2018) Xinguan Yang et al. LUNG CANCER
- Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC
- (2018) Tai H. Dou et al. PLoS One
- Value of 18F–FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients
- (2017) Zhilei Lv et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Associations between radiologist-defined semantic and automatically computed radiomic features in non-small cell lung cancer
- (2017) Stephen S. F. Yip et al. Scientific Reports
- Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations
- (2016) Tae Jung Kim et al. ANNALS OF THORACIC SURGERY
- Clinical and CT characteristics of surgically resected lung adenocarcinomas harboring ALK rearrangements or EGFR mutations
- (2016) Hua Wang et al. EUROPEAN JOURNAL OF RADIOLOGY
- Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT
- (2015) Takeo Nakada et al. Annals of Thoracic and Cardiovascular Surgery
- Role of Imaging Biomarkers in Predicting Anaplastic Lymphoma Kinase–Positive Lung Adenocarcinoma
- (2015) Chae Jin Jeong et al. CLINICAL NUCLEAR MEDICINE
- Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations
- (2015) J. Y. Zhou et al. EUROPEAN RADIOLOGY
- CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
- (2015) Stefania Rizzo et al. EUROPEAN RADIOLOGY
- Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma
- (2015) Weijing Cai et al. JOURNAL OF CLINICAL ONCOLOGY
- Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach
- (2015) Hyun Jung Yoon et al. MEDICINE
- Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma
- (2015) Federica Zito Marino et al. PLoS One
- Advanced Adenocarcinoma of the Lung: Comparison of CT Characteristics of Patients with Anaplastic Lymphoma Kinase Gene Rearrangement and Those with Epidermal Growth Factor Receptor Mutation
- (2015) Chang-Min Choi et al. RADIOLOGY
- Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?
- (2014) Darragh F. Halpenny et al. LUNG CANCER
- ALKMolecular Phenotype in Non–Small Cell Lung Cancer: CT Radiogenomic Characterization
- (2014) Shota Yamamoto et al. RADIOLOGY
- Anaplastic lymphoma kinase gene rearrangements in patients with advanced-stage non-small-cell lung cancer: CT characteristics and response to chemotherapy
- (2013) Jangchul Park et al. Cancer Medicine
- Epidemiology of Lung Cancer
- (2013) Carole Ridge et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene
- (2012) Takayuki Fukui et al. LUNG CANCER
- Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT
- (2012) Hongyoon Choi et al. LUNG CANCER
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
- (2011) Alice T Shaw et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now